Skip to main content
Fig. 5 | Stem Cell Research & Therapy

Fig. 5

From: Labial gland-derived mesenchymal stem cells and their exosomes ameliorate murine Sjögren's syndrome by modulating the balance of Treg and Th17 cells

Fig. 5

The proportion of Th17 and Treg cells. A, B The proportion of Treg (A) and Th17 (B) cells in PBMCs of systemic healthy donors and SS patients. C, D The proportion of Th17 cells (C) and Treg cells (D) in PBMCs from SS patients co-cultured with LGMSCs and GW4869-treated LGMSCs. E Cell number counting of LGMSCs and GW4869-treated LGMSCs. Data are shown as mean ± standard deviation (SD) from three independent experiments. ***p < 0.001, **p < 0.01, *p < 0.05. Th17 T helper 17; Treg T regulatory; PBMCs peripheral blood mononuclear lymphocytes; SS Sjögren's syndrome; LGMSCs labial gland-derived mesenchymal stem cells

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512